Nu Skin: The Turnaround Is Behind Before It's Started (NYSE:NUS)
· seekingalpha.com
Nu Skin hits a 25-year low as revenue slides. See valuation metrics (P/E, EV/EBITDA, 5%+ yield) and decide if it’s a value trap—read more on NUS stock.
Nu Skin Enterprises ( NUS ) stock trades at a 25-year low and is now valued below 7x the low end of full-year guidance for 2026 adjusted earnings per share. The...